Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human papillomavirus (HPV) vaccine.

Rates of precancerous lesions in women between the ages of 20 and 24 dropped by roughly 80 percent from 2008 to 2022, according to data published by the Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report.

About 10,800 cases of cervical cancer occur in the U.S. every year with most of them stemming from an........

© The Hill